CT vs X-ray for lung monitoring after sarcoma surgery
Part of Brain & nervous system, Cancer clinical trials.
This study compares two ways to monitor your lungs after surgery for a high-risk soft tissue sarcoma: chest CT scans versus chest X-rays. The goal is to see if one method is better at finding any return of cancer early, so you can get the right follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 85 years old.
- You had surgery to remove a high-grade (aggressive) soft tissue sarcoma from your trunk, arm, or leg, and the surgeon removed all visible cancer (R0 or R1 resection).
- Your tumor was at least 5 centimeters (about 2 inches) across.
- You had a chest CT within the last 30 days that showed no signs of cancer spread (or only very tiny spots 4 mm or smaller).
- You are not pregnant, and if you could become pregnant, you will have a pregnancy test before starting.
- You speak English (for the quality-of-life part of the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two schedules of post-treatment check-ups to see which one better supports patient quality of life. You’d fill out surveys for up to two years to measure how you feel over time.
This trial tests whether a shorter course of radiation therapy works as well as the standard longer course for soft tissue sarcomas (a type of muscle or tissue cancer) that need surgery. The goal is to see if patients can get the same benefit with less treatment time and side effects.
This trial tests a shorter, 3-week course of radiation therapy (using protons or standard X-rays) given before surgery for localized soft tissue sarcoma. It aims to see if this approach is safe and effective for treating the tumor while reducing side effects.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This trial tests combining anlotinib (a targeted therapy), doxorubicin (chemotherapy), and radiation given before surgery to shrink high-grade soft tissue sarcomas. The goal is to make the tumor easier to remove and improve outcomes.
This trial studies when to do surgery after a short course of radiation for soft tissue sarcoma in the arms, legs, or trunk. It aims to find the best timing to improve outcomes and reduce side effects.
Hear when a new Alveolar Soft Part Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.